Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens.

Hollemans E, Verhoef EI, Bangma CH, Schoots I, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH.

Histopathology. 2019 May 2. doi: 10.1111/his.13893. [Epub ahead of print]

PMID:
31045262
2.

Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.

Duijvesz D, Rodriguez-Blanco G, Hoogland AM, Verhoef EI, Dekker LJ, Roobol MJ, van Leenders GJLH, Luider TM, Jenster G.

Prostate. 2019 Jun;79(9):1032-1042. doi: 10.1002/pros.23813. Epub 2019 Apr 24.

3.

PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.

Agahozo MC, Sieuwerts AM, Doebar SC, Verhoef E, Beaufort CM, Ruigrok-Ritstier K, de Weerd V, Sleddens HFBM, Dinjens WN, Martens J, van Deurzen C.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0019.R1. doi: 10.1530/ERC-19-0019. [Epub ahead of print]

PMID:
30844755
4.

Three-dimensional architecture of common benign and precancerous prostate epithelial lesions.

Verhoef EI, van Cappellen WA, Slotman JA, Kremers GJ, Ewing-Graham PC, Houtsmuller AB, van Royen ME, van Leenders GJLH.

Histopathology. 2019 Jun;74(7):1036-1044. doi: 10.1111/his.13848. Epub 2019 Apr 21.

PMID:
30815904
5.

Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns.

Verhoef EI, van Cappellen WA, Slotman JA, Kremers GJ, Ewing-Graham PC, Houtsmuller AB, van Royen ME, van Leenders GJLH.

Mod Pathol. 2019 Jul;32(7):1032-1041. doi: 10.1038/s41379-019-0221-0. Epub 2019 Feb 8.

PMID:
30737469
6.

Disentangling polygenic associations between attention-deficit/hyperactivity disorder, educational attainment, literacy and language.

Verhoef E, Demontis D, Burgess S, Shapland CY, Dale PS, Okbay A, Neale BM, Faraone SV; iPSYCH-Broad-PGC ADHD Consortium, Stergiakouli E, Davey Smith G, Fisher SE, Børglum AD, St Pourcain B.

Transl Psychiatry. 2019 Jan 24;9(1):35. doi: 10.1038/s41398-018-0324-2.

7.

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer.

Rodríguez-Blanco G, Zeneyedpour L, Duijvesz D, Hoogland AM, Verhoef EI, Kweldam CF, Burgers PC, Smitt PS, Bangma CH, Jenster G, van Leenders GJLH, Dekker LJM, Luider TM.

Oncotarget. 2018 Nov 23;9(92):36444-36456. doi: 10.18632/oncotarget.26342. eCollection 2018 Nov 23.

8.

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.

Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH.

Mod Pathol. 2019 Jan;32(1):139-146. doi: 10.1038/s41379-018-0157-9. Epub 2018 Oct 22.

9.

Imaging genetics in neurodevelopmental psychopathology.

Klein M, van Donkelaar M, Verhoef E, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jul;174(5):485-537. doi: 10.1002/ajmg.b.32542. Review.

PMID:
29984470
10.

Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression.

Kolijn K, Verhoef EI, Smid M, Böttcher R, Jenster GW, Debets R, van Leenders GJLH.

Cancer Res. 2018 Aug 15;78(16):4671-4679. doi: 10.1158/0008-5472.CAN-17-3752. Epub 2018 Jun 19.

PMID:
29921693
11.

Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model.

Mout L, de Wit R, Stuurman D, Verhoef E, Mathijssen R, de Ridder C, Lolkema M, van Weerden W.

EBioMedicine. 2018 Jan;27:182-186. doi: 10.1016/j.ebiom.2017.12.024. Epub 2017 Dec 20.

12.

Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.

Verhoef EI, Kweldam CF, Kümmerlin IP, Nieboer D, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ.

Histopathology. 2018 Apr;72(5):760-765. doi: 10.1111/his.13427. Epub 2018 Jan 14.

PMID:
29094386
13.

A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.

Chua MLK, Lo W, Pintilie M, Murgic J, Lalonde E, Bhandari V, Mahamud O, Gopalan A, Kweldam CF, van Leenders GJLH, Verhoef EI, Hoogland AM, Livingstone J, Berlin A, Dal Pra A, Meng A, Zhang J, Orain M, Picard V, Hovington H, Bergeron A, Lacombe L, Fradet Y, Têtu B, Reuter VE, Fleshner N, Fraser M, Boutros PC, van der Kwast TH, Bristow RG.

Eur Urol. 2017 Nov;72(5):665-674. doi: 10.1016/j.eururo.2017.04.034. Epub 2017 May 13.

PMID:
28511883
14.

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.

Zoni E, Chen L, Karkampouna S, Granchi Z, Verhoef EI, La Manna F, Kelber J, Pelger RCM, Henry MD, Snaar-Jagalska E, van Leenders GJLH, Beimers L, Kloen P, Gray PC, van der Pluijm G, Kruithof-de Julio M.

Oncogene. 2017 Aug 17;36(33):4739-4749. doi: 10.1038/onc.2017.87. Epub 2017 Apr 10.

15.

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.

Hoogland AM, Böttcher R, Verhoef E, Jenster G, van Leenders GJ.

Oncotarget. 2016 Jun 21;7(25):37846-37856. doi: 10.18632/oncotarget.9344.

16.

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.

Böttcher R, Dulla K, van Strijp D, Dits N, Verhoef EI, Baillie GS, van Leenders GJ, Houslay MD, Jenster G, Hoffmann R.

Oncotarget. 2016 Oct 25;7(43):70669-70684. doi: 10.18632/oncotarget.12204.

17.

Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.

Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ, van Leenders GJ.

Eur J Cancer. 2016 Oct;66:26-33. doi: 10.1016/j.ejca.2016.07.012. Epub 2016 Aug 11.

PMID:
27522247
18.

Three-dimensional microscopic analysis of clinical prostate specimens.

van Royen ME, Verhoef EI, Kweldam CF, van Cappellen WA, Kremers GJ, Houtsmuller AB, van Leenders GJ.

Histopathology. 2016 Dec;69(6):985-992. doi: 10.1111/his.13022. Epub 2016 Sep 21.

PMID:
27353346
19.

MET expression during prostate cancer progression.

Verhoef EI, Kolijn K, De Herdt MJ, van der Steen B, Hoogland AM, Sleddens HF, Looijenga LH, van Leenders GJ.

Oncotarget. 2016 May 24;7(21):31029-36. doi: 10.18632/oncotarget.8829.

20.

Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.

Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, van der Kwast TH, Roobol MJ, van Leenders GJ.

Mod Pathol. 2016 Jun;29(6):630-6. doi: 10.1038/modpathol.2016.49. Epub 2016 Mar 4.

21.

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.

De Herdt MJ, Willems SM, van der Steen B, Noorlag R, Verhoef EI, van Leenders GJ, van Es RJ, KoljenoviÄ S, Baatenburg de Jong RJ, Looijenga LH.

Oncotarget. 2016 Mar 15;7(11):13167-81. doi: 10.18632/oncotarget.7534.

22.

Insulin Pumps and Remote Software Updates: A New Way Forward.

Schaeffer NE, Parks LJ, Verhoef ET, Morgan CA, Stal M.

J Diabetes Sci Technol. 2015 Sep 18;10(2):453-6. doi: 10.1177/1932296815604857.

23.
24.

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.

Böttcher R, Hoogland AM, Dits N, Verhoef EI, Kweldam C, Waranecki P, Bangma CH, van Leenders GJ, Jenster G.

Oncotarget. 2015 Feb 28;6(6):4036-50.

25.

SYK is a candidate kinase target for the treatment of advanced prostate cancer.

Ghotra VP, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, Janssen R, Jenster G, van Leenders GJ, Hoogland AM, Verhoef EI, Baranski Z, Xiong J, van de Water B, van der Pluijm G, Snaar-Jagalska BE, Danen EH.

Cancer Res. 2015 Jan 1;75(1):230-40. doi: 10.1158/0008-5472.CAN-14-0629. Epub 2014 Nov 11.

26.

Usability and training differences between two personal insulin pumps.

Schaeffer NE, Parks LJ, Verhoef ET, Bailey TS, Schorr AB, Davis T, Halford J, Sulik B.

J Diabetes Sci Technol. 2015 Mar;9(2):221-30. doi: 10.1177/1932296814555158. Epub 2014 Oct 14.

27.

Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.

Hoogland AM, Verhoef EI, Roobol MJ, Schröder FH, Wildhagen MF, van der Kwast TH, Jenster G, van Leenders GJ.

Prostate. 2014 May;74(5):488-96. doi: 10.1002/pros.22768. Epub 2013 Dec 27.

PMID:
24375374
28.

Effects of Pay-As-You-Drive vehicle insurance on young drivers' speed choice: results of a Dutch field experiment.

Bolderdijk JW, Knockaert J, Steg EM, Verhoef ET.

Accid Anal Prev. 2011 May;43(3):1181-6. doi: 10.1016/j.aap.2010.12.032. Epub 2011 Jan 26.

PMID:
21376917
29.

Slipped capital femoral epiphyses associated with the withdrawal of a gonadotrophin releasing hormone.

van Puijenbroek E, Verhoef E, de Graaf L.

BMJ. 2004 Jun 5;328(7452):1353. No abstract available.

30.

The value of statistical life in road safety: a meta-analysis.

de Blaeij A, Florax RJ, Rietveld P, Verhoef E.

Accid Anal Prev. 2003 Nov;35(6):973-86.

PMID:
12971932
31.

Stoichiometry and kinetics of poly-beta-hydroxybutyrate metabolism under denitrifying conditions in activated sludge cultures.

Beun JJ, Verhoef EV, Van Loosdrecht MC, Heijnen JJ.

Biotechnol Bioeng. 2000 Jun 5;68(5):496-507.

PMID:
10797235
32.

[Vaccination against influenza superfluous in patients with (recurrent) staphylococcal infections].

Sigurdsson V, Lammers JW, Verhoef EA, van Vloten WA.

Ned Tijdschr Geneeskd. 1995 Nov 11;139(45):2316-7. Dutch. No abstract available.

PMID:
7501066
33.

Mechanism of the inhibitory actions of some spasmogens on the bradykinin relaxation of the guinea-pig ileum.

Hall DW, Bonta IL, Verhoef ER.

Eur J Pharmacol. 1974 Mar;25(3):308-15. No abstract available.

PMID:
4363949

Supplemental Content

Loading ...
Support Center